1315 CAPITAL
1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and digital health. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$20 million investments in commercial healthcare entities that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.
1315 CAPITAL
Industry:
Finance Financial Services Venture Capital
Founded:
2014-01-01
Status:
Active
Contact:
+1 215 662 1315
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Alterna Capital Partners
Alterna invests in Core Capital Assets for the transportation, industrial and energy sectors.
Attain Capital Partners
Attain Capital Partners invests in growth-stage companies in the knowledge economy.
Brain-Too-Free Ventures
Brain-Too-Free Ventures provide inorganic growth capital and shareholder liquidity for rapidly growing, privately-held companies.
Camden Partners
Camden Partners provides growth capital to companies in the education, healthcare and technology-enabled business services sectors.
Country Garden Venture Capital
Country Garden Venture Capital focuses on the four major investment themes of industrial chain, technology, health, and consumption.
Fannin Innovation Studio
Fannin Innovation Studio focuses on commercializing innovation developed in the Texas Medical Center institutions.
Hopewell Ventures
Hopewell Ventures provides equity capital and strategic expertise to high-growth businesses, primarily in the Midwest.
July Ventures
July Ventures provides patient capital and partners with passionate entrepreneurs in building and scaling their businesses.
Nickleby Capital
Nickleby Capital provides investment capital to help accelerate growth in high-potential companies.
RiverGlade Capital
RiverGlade Capital is a growth-oriented private equity firm that invests in healthcare services companies.
Route 66 Ventures
Route 66 Ventures provides venture capital and credit solutions to emerging financial technology and services companies.
Spring Lane Capital
Spring Lane Capital offers a new approach to faster growth for companies that deploy smaller-scale projects and equipment.
Synergy Ventures
Synergy has been actively involved in medical technology and venture capital since 1996.
The Conscious Fund
The Conscious Fund invests in early stage ventures in plant-powered medicine.
Xerox Venture Capital
Xerox Venture Capital Companies whose technology or products are strategically relevant to Xerox.
Current Advisors List
Board_member
2015-01-01
Current Employees Featured
Michael Koby Co-Founder & Partner @ 1315 Capital
Co-Founder & Partner
2014-05-01
Craig Matturro Principal @ 1315 Capital
Principal
2022-06-01
Brian Schwenk Chief Financial Officer & Chief Compliance Officer @ 1315 Capital
Chief Financial Officer & Chief Compliance Officer
2014-04-01
Ian Li Principal @ 1315 Capital
Principal
2022-06-01
Gregory Muir Senior Associate @ 1315 Capital
Senior Associate
Edward Chan Partner @ 1315 Capital
Partner
2021-06-01
Paul Touhey Operating Partner @ 1315 Capital
Operating Partner
2016-06-01
Jordan Brown Vice President @ 1315 Capital
Vice President
Carter Cortazzi Associate @ 1315 Capital
Associate
2022-07-01
Jessica Hou Partner @ 1315 Capital
Partner
2022-01-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-30 | Homestead Smart Health Plans | Homestead Smart Health Plans acquired by 1315 Capital | N/A |
| 2021-05-11 | miraDry | miraDry acquired by 1315 Capital | N/A |
| 2019-01-16 | Biocoat | Biocoat acquired by 1315 Capital | N/A |
| 2018-10-17 | Centurion Service Group | Centurion Service Group acquired by 1315 Capital | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-13 | NutriSense | 1315 Capital investment in Series A - NutriSense | 25 M USD |
| 2021-09-01 | Onkos Surgical | 1315 Capital investment in Series C - Onkos Surgical | 22.5 M USD |
| 2019-04-08 | Encore Dermatology | 1315 Capital investment in Debt Financing - Encore Dermatology | 20 M USD |
| 2017-11-09 | Misonix | 1315 Capital investment in Post-IPO Equity - Misonix | 25 M USD |
| 2017-07-21 | Colorescience | 1315 Capital investment in Series C - Colorescience | 15 M USD |
| 2017-04-19 | Onkos Surgical | 1315 Capital investment in Series B - Onkos Surgical | 17.6 M USD |
| 2015-10-31 | JDS Therapeutics LLC | 1315 Capital investment in Private Equity Round - JDS Therapeutics LLC | 16 M USD |
| 2015-10-06 | Onkos Surgical | 1315 Capital investment in Series A - Onkos Surgical | N/A |
More informations about "1315 Capital"
Financial Portfolio | Partner of Choice - 1315 Capital
1315 Capital has partnered with many healthcare companies that have thrived due to the firm’s valuable industry insight and hands-on approach. Investor Login; Home; ... Specialty clinical …See details»
1315 Capital - Crunchbase Investor Profile & Investments
1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and …See details»
Investment Leadership | Operating Teams | 1315 Capital
1315 Capital investment partners have been investing exclusively in expansion and growth stage healthcare companies their entire careers, with proven results through multiple market cycles. The investment partners marry expertise in …See details»
1315 Capital investment portfolio - PitchBook
1315 Capital General Information Company Description. Founded in 2014, 1315 Capital is a growth investment capital firm based in Philadelphia, Pennsylvania. The firm prefers to invest …See details»
1315 Capital - Investments, Funds & Exits
1315 Capital specializes in providing expansion and growth capital to commercial-stage healthcare services, medical technology, medtech & pharma outsourcing, and health & …See details»
Experic Announces Growth Capital Investment Led by 1315 Capital
Oct 29, 2024 Experic is a contract development and manufacturing organization ... 1315 Capital is a private investment firm with over $1 billion of assets under management that provides …See details»
1315 Capital - Investments, Portfolio & Company Exits - Crunchbase
1315 Capital 's most notable exits include Colorescience, Interpace Biosciences, and Misonix. 1315 Capital has acquired 5 organizations. Their most recent acquisition was SciSafe on Nov …See details»
1315 Capital - Funding, Financials, Valuation & Investors
1315 Capital has raised 4 funds, their latest being 1315 Capital Emerging Growth and Buyout. This fund was announced on Oct 23, 2023 and raised a total of . obfuscated. obfuscated. …See details»
1315 Capital - Portfolio, Partners, Reviews, News
1315 Capital provides expansion and growth capital to commercial-stage healthcare services, medical technology, and specialty therapeutics companies, the latter including businesses …See details»
Capital AUM | 1315 Capital Overview
Oct 23, 2023: 1315 Capital Closes Two Funds, Raising over $500 Million to Invest in Commercial-Stage Healthcare Companies 1315 Capital , a private investment firm that provides growth …See details»
1315 Capital - Private Equity Investments & Executives
See 1315 Capital's 24 investments, 17 executives, and complete investor profile. Founded in 2014, 1315 Capital is a private investment firm that provides expansion and growth capital to …See details»
ProSciento Closes Growth Financing from 1315 Capital
SAN DIEGO and PHILADELPHIA, September 10, 2020 /Businesswire/ – ProSciento, Inc., a leading specialty clinical research organization (CRO) focused on non-alcoholic steatohepatitis …See details»
Navigator Global acquires 23.5% stake in 1315 Capital for $70.5m
4 days ago The investment will not affect 1315 Capital’s management structure or investment decision-making processes. Navigator will fund the deal using its existing resources and has …See details»
1315 Capital - teaserclub.com
1315 Capital is a Philadelphia-based private equity firm founded in 2014, specializing in providing expansion and growth capital to commercial-stage specialty pharmaceutical, medical …See details»
Navigator Global Invests in 1315 Capital - Sharecafe
4 days ago Navigator Global has announced its acquisition of a 23.5% minority stake in US-based private equity firm 1315 Capital for $70.5 million USD ($111.44 million AUD). 1315 …See details»
Navigator Global Investments Acquires Stake in 1315 Capital
2 days ago Ropes & Gray advised 1315 Capital, a healthcare private equity firm, in connection with Navigator Global Investments' acquisition of a 23.5% strategic equity stake in 1315 …See details»
1315 Capital | Institution Profile - Private Equity International
1315 Capital raises $300m. The US-based expansion and growth equity firm closes second fund at hard-cap. Get access to all 1315 Capital news and analysis > 1315 Capital contact …See details»
1315 Capital - Philadelphia Alliance for Capital & Technologies …
1315 Capital provides venture expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies. Led by co-founders …See details»
Press Release Archives - 1315 Capital
Experic, a US-based contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the global biopharmaceutical industry, today announced …See details»
Navigator takes stake in 1315 Capital | Financial Standard
5 days ago 1315 Capital targets up to US$40 million investments in healthcare firms that have the potential to scale to US$50 million to US$150 million of revenue. Upon signing the …See details»